TOKYO -- A Chinese lab attempting to patent the use of anti-flu drug Avigan for the treatment of COVID-19 is facing pushback in Japan, where the medicine was originally developed.
Coronavirus
Chinese pursuit of Avigan patent faces pushback in Japan
Fujifilm intellectual property cited as reason to 'reject' Beijing lab's application
